Zhejiang Jiuzhou Pharmaceutical Co Ltd

Zhejiang Jiuzhou Pharmaceutical Co Ltd

Health CarePharmaceuticals & Biotechnology
  • Price (CNY)44.60
  • Today's Change-1.26 / -2.75%
  • Shares traded8.83m
  • 1 Year change+20.22%
  • Beta0.9663
Data delayed at least 15 minutes, as of Jul 23 2021 08:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, production and sales of chemical Active Pharmaceutical Ingredients (API) and intermediates. The Company mainly operates through two segments, including the New Drug and Intermediates Contract Development and Manufacturing Organization (CDMO) segment and the Specialty APIs and Intermediates segment. The New Drug and Intermediates CDMO segment mainly provides services for innovative medicines of pre-clinical chemical manufacturing and controls (CMC), clinical phases I, II and III, new drug application (NDA) and various stages after going public. The Specialty API and Intermediates segments mainly provides services including patent breakthroughs, production process improvement, drug certificate declaration, and cGMP standard commercial production for patented expired or soon-to-be-expired drugs for global chemical and generic drug manufacturers.

  • Revenue in CNY (TTM)3.11bn
  • Net income in CNY442.54m
  • Incorporated1998
  • Employees3.59k
  • Location
    Zhejiang Jiuzhou Pharmaceutical Co LtdNo.99, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
  • Phone+86 57 688706789
  • Fax+86 57 688706788
  • Websitehttp://www.jiuzhoupharma.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
HuBei XingFa Chemical Group Co Ltd18.88bn954.36m30.80bn11.54k30.833.08--1.630.8930.89317.818.930.63847.8913.951,635,960.003.312.096.624.3517.9114.975.183.030.40783.600.531344.221.548.13141.9251.85-6.3224.57
Jiangsu Cnano Technology Co Ltd630.24m147.67m32.45bn234.00219.7318.87--51.490.63690.63692.727.420.32815.424.932,693,332.007.66--8.51--37.77--23.34--5.54--0.0847--22.13---2.58------
Zhejiang Juhua Co., Ltd16.16bn96.61m32.45bn6.78k320.452.60--2.010.03750.03756.174.631.0010.7624.492,384,891.000.69896.270.86287.3810.1015.930.69635.971.70--0.052441.61-0.085911.03-89.39-10.0321.485.39
Yunnan Yuntianhua Co., Ltd.54.16bn835.82m32.98bn11.85k36.304.69--0.6090.49450.494535.303.830.92516.5815.224,572,030.001.78-0.70389.34-3.7411.9311.351.93-0.83970.47472.130.7901---3.460.723179.0921.87-15.34--
Jiangsu Yangnong Chemical Co.,Ltd.10.38bn1.21bn36.91bn3.12k30.565.81--3.563.903.9033.5020.510.90565.754.433,330,577.0010.5510.9818.3819.6824.6826.9611.6512.961.3427.130.275322.3912.9825.853.4121.6028.717.63
Zhejiang Jiuzhou Pharmaceutical Co Ltd3.11bn442.54m37.08bn3.59k82.368.87--11.920.54150.54153.805.030.58271.825.68867,782.608.285.6411.317.0534.7132.4514.2110.421.1812.100.132360.1231.2612.8860.0513.721.0119.14
Zhejiang Longsheng Group Co., Ltd15.58bn4.07bn42.23bn8.28k10.231.47--2.711.271.274.868.850.27580.39885.241,880,698.007.618.2510.9511.9639.3940.5727.6122.890.7981--0.41425.49-26.960.9915-16.869.261.9110.76
Shandong Shida Shenghua Chemicl Gp CoLtd5.29bn509.44m44.24bn1.57k85.1419.29--8.362.562.5626.3011.321.5610.1213.573,377,604.0015.198.7724.4314.0220.2413.039.765.171.9426.740.073943.03-3.625.31-15.7842.56-3.3043.10
Data as of Jul 23 2021. Currency figures normalised to Zhejiang Jiuzhou Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

13.60%Per cent of shares held by top holders
HolderShares% Held
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 202034.19m4.26%
Caitong Fund Management Co., Ltd.as of 31 Dec 202017.69m2.20%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 202015.14m1.89%
Great Wall Fund Management Co., Ltd.as of 31 Dec 20208.43m1.05%
Baoying Fund Management Co., Ltd.as of 31 Dec 20207.75m0.97%
Harvest Fund Management Co., Ltd.as of 31 Mar 20217.14m0.89%
Tibet Longrising Asset Management Co. Ltd.as of 31 Mar 20216.14m0.77%
China Asset Management Co., Ltd.as of 31 Dec 20205.22m0.65%
Guotai Asset Management Co., Ltd.as of 31 Dec 20203.86m0.48%
Bosera Asset Management Co., Ltd.as of 31 Dec 20203.71m0.46%
More ▼
Data from 31 Dec 2020 - 22 Jul 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.